Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2025.
Board Meeting Intimation for Inter-Alia, To Consider, Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2025.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Omkar Pharmachem Ltd. on 6ix
Story so far
- Board Meeting Intimation for Board Meeting Intimation For Approval Of Audited Financial Results For Quarter And Year Ended On 31St March 2025
- Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results Of The Company For Quarter Ended On 31St December 2024.
Earlier from Omkar Pharmachem
- Omkar Pharmachem Ltd. Press Release Jul 10 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Omkar Pharmachem Ltd. Press Release Jun 28 2025
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Omkar Pharmachem Ltd. Press Release Jun 26 2025
Later from Omkar Pharmachem
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August, 2025
- Omkar Pharmachem Ltd. Press Release Aug 13 2025
- Results- Financial Results For June 2025
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 27Th August, 2025
- Omkar Pharmachem Ltd. Press Release Aug 27 2025
Follow Omkar Pharmachem into a list and get an email when it puts out news.
Follow Omkar Pharmachem